Taiwan · Delayed Price · Currency is TWD Microbio Statistics
Total Valuation
Microbio has a market cap or net worth of TWD 8.88 billion. The enterprise value is 7.94 billion.
| Market Cap | 8.88B |
| Enterprise Value | 7.94B |
Important Dates
The next estimated earnings date is Thursday, November 12, 2026.
| Earnings Date | Nov 12, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
Microbio has 588.17 million shares outstanding. The number of shares has increased by 0.36% in one year.
| Current Share Class | 588.17M |
| Shares Outstanding | 588.17M |
| Shares Change (YoY) | +0.36% |
| Shares Change (QoQ) | -0.35% |
| Owned by Insiders (%) | 1.84% |
| Owned by Institutions (%) | 3.43% |
| Float | 422.88M |
Valuation Ratios
The trailing PE ratio is 17.07.
| PE Ratio | 17.07 |
| Forward PE | n/a |
| PS Ratio | 4.52 |
| PB Ratio | 0.83 |
| P/TBV Ratio | 0.95 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | 15.18 |
| EV / Sales | 4.04 |
| EV / EBITDA | 18.19 |
| EV / EBIT | 31.88 |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 6.07, with a Debt / Equity ratio of 0.07.
| Current Ratio | 6.07 |
| Quick Ratio | 5.33 |
| Debt / Equity | 0.07 |
| Debt / EBITDA | n/a |
| Debt / FCF | -2.92 |
| Interest Coverage | -36.54 |
Financial Efficiency
Return on equity (ROE) is 2.48% and return on invested capital (ROIC) is -5.69%.
| Return on Equity (ROE) | 2.48% |
| Return on Assets (ROA) | -2.33% |
| Return on Invested Capital (ROIC) | -5.69% |
| Return on Capital Employed (ROCE) | -3.81% |
| Weighted Average Cost of Capital (WACC) | 6.36% |
| Revenue Per Employee | n/a |
| Profits Per Employee | n/a |
| Employee Count | n/a |
| Asset Turnover | 0.16 |
| Inventory Turnover | 5.32 |
Taxes
In the past 12 months, Microbio has paid 1.96 million in taxes.
| Income Tax | 1.96M |
| Effective Tax Rate | 0.74% |
Stock Price Statistics
The stock price has decreased by -38.62% in the last 52 weeks. The beta is 0.45, so Microbio's price volatility has been lower than the market average.
| Beta (5Y) | 0.45 |
| 52-Week Price Change | -38.62% |
| 50-Day Moving Average | 15.29 |
| 200-Day Moving Average | 17.61 |
| Relative Strength Index (RSI) | 52.10 |
| Average Volume (20 Days) | 1,352,264 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, Microbio had revenue of TWD 1.97 billion and earned 523.23 million in profits. Earnings per share was 0.88.
| Revenue | 1.97B |
| Gross Profit | 778.39M |
| Operating Income | -467.59M |
| Pretax Income | 263.36M |
| Net Income | 523.23M |
| EBITDA | -367.36M |
| EBIT | -467.59M |
| Earnings Per Share (EPS) | 0.88 |
Balance Sheet
The company has 2.84 billion in cash and 708.04 million in debt, with a net cash position of 2.13 billion or 3.62 per share.
| Cash & Cash Equivalents | 2.84B |
| Total Debt | 708.04M |
| Net Cash | 2.13B |
| Net Cash Per Share | 3.62 |
| Equity (Book Value) | 10.69B |
| Book Value Per Share | 16.21 |
| Working Capital | 2.78B |
Cash Flow
In the last 12 months, operating cash flow was -193.40 million and capital expenditures -49.15 million, giving a free cash flow of -242.55 million.
| Operating Cash Flow | -193.40M |
| Capital Expenditures | -49.15M |
| Depreciation & Amortization | 100.23M |
| Net Borrowing | -165.01M |
| Free Cash Flow | -242.55M |
| FCF Per Share | -0.41 |
Margins
Gross margin is 39.60%, with operating and profit margins of -23.79% and 26.62%.
| Gross Margin | 39.60% |
| Operating Margin | -23.79% |
| Pretax Margin | 13.40% |
| Profit Margin | 26.62% |
| EBITDA Margin | -18.69% |
| EBIT Margin | -23.79% |
| FCF Margin | n/a |
Dividends & Yields
Microbio does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -0.36% |
| Shareholder Yield | -0.36% |
| Earnings Yield | 5.89% |
| FCF Yield | -2.73% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | |
| Graham Upside |
Stock Splits
The last stock split was on August 29, 2024. It was a forward split with a ratio of 1.049999998.
| Last Split Date | Aug 29, 2024 |
| Split Type | Forward |
| Split Ratio | 1.049999998 |
Scores
| Altman Z-Score | n/a |
| Piotroski F-Score | 3 |